Neuroactive steroids alphaxalone and CDNC24 are effective hypnotics and potentiators of GABAA currents, but are not neurotoxic to the developing rat brain

Br J Anaesth. 2020 May;124(5):603-613. doi: 10.1016/j.bja.2020.01.013. Epub 2020 Mar 6.

Abstract

Background: The most currently used general anaesthetics are potent potentiators of γ-aminobutyric acid A (GABAA) receptors and are invariably neurotoxic during the early stages of brain development in preclinical animal models. As causality between GABAA potentiation and anaesthetic-induced developmental neurotoxicity has not been established, the question remains whether GABAergic activity is crucial for promoting/enhancing neurotoxicity. Using the neurosteroid analogue, (3α,5α)-3-hydroxy-13,24-cyclo-18,21-dinorchol-22-en-24-ol (CDNC24), which potentiates recombinant GABAA receptors, we examined whether this potentiation is the driving force in inducing neurotoxicity during development.

Methods: The neurotoxic potential of CDNC24 was examined vis-à-vis propofol (2,6-diisopropylphenol) and alphaxalone (5α-pregnan-3α-ol-11,20-dione) at the peak of rat synaptogenesis. In addition to the morphological neurotoxicity studies of the subiculum and medial prefrontal cortex (mPFC), we assessed the extra-, pre-, and postsynaptic effects of these agents on GABAergic neurotransmission in acute subicular slices from rat pups.

Results: CDNC24, like alphaxalone and propofol, caused dose-dependent hypnosis in vivo, with a higher therapeutic index. CDNC24 and alphaxalone, unlike propofol, did not cause developmental neuroapoptosis in the subiculum and mPFC. Propofol potentiated post- and extrasynaptic GABAA currents as evidenced by increased spontaneous inhibitory postsynaptic current (sIPSC) decay time and prominent tonic currents, respectively. CDNC24 and alphaxalone had a similar postsynaptic effect, but also displayed a strong presynaptic effect as evidenced by decreased frequency of sIPSCs and induced moderate tonic currents.

Conclusions: The lack of neurotoxicity of CDNC24 and alphaxalone may be at least partly related to suppression of presynaptic GABA release in the developing brain.

Keywords: general anaesthetic; prefrontal cortex; presynaptic; subiculum; synaptic transmission; synaptogenesis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Dose-Response Relationship, Drug
  • GABA-A Receptor Agonists / administration & dosage
  • GABA-A Receptor Agonists / pharmacology
  • GABA-A Receptor Agonists / toxicity
  • Hippocampus / drug effects
  • Hippocampus / growth & development
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Hypnotics and Sedatives / administration & dosage
  • Hypnotics and Sedatives / pharmacology
  • Hypnotics and Sedatives / toxicity*
  • Inhibitory Postsynaptic Potentials / drug effects
  • Neurotoxicity Syndromes / etiology
  • Neurotoxicity Syndromes / pathology
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / growth & development
  • Prefrontal Cortex / pathology
  • Pregnanediones / administration & dosage
  • Pregnanediones / pharmacology
  • Pregnanediones / toxicity*
  • Propofol / administration & dosage
  • Propofol / pharmacology
  • Propofol / toxicity
  • Rats, Sprague-Dawley
  • Receptors, GABA-A / metabolism
  • Steroids / administration & dosage
  • Steroids / pharmacology
  • Steroids / toxicity*
  • Synapses / drug effects
  • Synapses / physiology

Substances

  • CDNC24 steroid
  • GABA-A Receptor Agonists
  • Hypnotics and Sedatives
  • Pregnanediones
  • Receptors, GABA-A
  • Steroids
  • alphaxalone
  • Propofol